FDA Awards 21 Grants for Rare Disease Product Development

New clinical research grants totaling more than $23 million have been awarded to support the development of diagnostics and treatments for patients with rare disease. More than 40% of the awards focus on treatments for children. The grants were awarded to investigators from academia and industry in the US and abroad through the FDA’s Office of Orphan Product Development.